Comparison of cytochrome P450 2C9 genotyping methods and implications for the clinical laboratory.
about
Genotyping the GGGCGG tandem repeat promoter polymorphism in the 5-lipoxygenase enzyme gene (ALOX5) by pyrosequencing assay.Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patientsNovel single nucleotide polymorphism in CYP2C9 is associated with changes in warfarin clearance and CYP2C9 expression levels in African Americans.Genetic-based dosing in orthopedic patients beginning warfarin therapy.Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy.Pharmacogenetics in psychiatry: are we ready for widespread clinical use?A rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding.Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarinMolecular diagnostics for pharmacogenomic testing of fluoropyrimidine based-therapy: costs, methods and applications.Genetic polymorphisms are associated with variations in warfarin maintenance dose in Han Chinese patients with venous thromboembolism.Sequence analysis of the N-acetyltransferase 2 gene (NAT2) among Jordanian volunteers.Development of a single-tube PCR-pyrosequencing method for the simultaneous and rapid detection of four variant alleles of CYP2C9 gene polymorphism.
P2860
Q34385384-DC91B804-1A3B-492C-AF0D-591EE12040D5Q34571746-BE5C2C92-EA83-472A-94E3-8E9403D05B2AQ35612111-F606DA1A-943E-4D80-948F-ABF585EF1D57Q35989429-AABFA5BC-E190-4961-807F-BBE83E7B8CE7Q37031513-D0BFFD79-9494-4016-8E95-5230608726D0Q37076472-F5874C75-81F9-45DE-A6A0-52DB459F8CA4Q37087333-86167DEE-E8D4-4AEE-8428-F4E3BF2199B6Q37196787-D1C6A37D-43CD-414D-995A-D54ACF72A252Q37866805-679C974B-459E-42A8-8121-43D16B2DF795Q42722363-34BB8B41-6D66-4359-B4A5-9F29BD3508CDQ46496343-D183950C-EB9C-4AC2-A115-381D0D6B152AQ46721820-F10F78AA-C85E-4570-AF29-436DC8D7C8E5
P2860
Comparison of cytochrome P450 2C9 genotyping methods and implications for the clinical laboratory.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Comparison of cytochrome P450 ...... s for the clinical laboratory.
@en
type
label
Comparison of cytochrome P450 ...... s for the clinical laboratory.
@en
prefLabel
Comparison of cytochrome P450 ...... s for the clinical laboratory.
@en
P2093
P2860
P1433
P1476
Comparison of cytochrome P450 ...... s for the clinical laboratory.
@en
P2093
Christina L Aquilante
Julie A Johnson
Maximilian T Lobmeyer
Taimour Y Langaee
P2860
P304
P356
10.1592/PHCO.24.8.720.36074
P407
P577
2004-06-01T00:00:00Z